208 related articles for article (PubMed ID: 36302751)
1. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation.
Ou B; Liu Y; Gao Z; Xu J; Yan Y; Li Y; Zhang J
Cell Death Dis; 2022 Oct; 13(10):905. PubMed ID: 36302751
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
3. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
4. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.
Wang Y; Cheng Z; Xu J; Lai M; Liu L; Zuo M; Dang L
Bioengineered; 2021 Dec; 12(1):1874-1889. PubMed ID: 34076564
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
6. Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.
Xiao P; Liu YK; Han W; Hu Y; Zhang BY; Liu WL
Mol Cancer Res; 2021 Apr; 19(4):726-738. PubMed ID: 33563765
[TBL] [Abstract][Full Text] [Related]
7. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
[TBL] [Abstract][Full Text] [Related]
8. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB
Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075
[TBL] [Abstract][Full Text] [Related]
10. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
11. FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p.
Lin W; Mo CQ; Kong LJ; Chen L; Wu KL; Wu X
Kaohsiung J Med Sci; 2023 Sep; 39(9):873-882. PubMed ID: 37584416
[TBL] [Abstract][Full Text] [Related]
12. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the FTO m
Jeschke J; Collignon E; Al Wardi C; Krayem M; Bizet M; Jia Y; Garaud S; Wimana Z; Calonne E; Hassabi B; Morandini R; Deplus R; Putmans P; Dube G; Singh NK; Koch A; Shostak K; Rizzotto L; Ross RL; Desmedt C; Bareche Y; Rothé F; Lehmann-Che J; Duterque-Coquillaud M; Leroy X; Menschaert G; Teixeira L; Guo M; Limbach PA; Close P; Chariot A; Leucci E; Ghanem G; Yuan BF; Willard-Gallo K; Sotiriou C; Marine JC; Fuks F
Nat Cancer; 2021 Jun; 2(6):611-628. PubMed ID: 35121941
[TBL] [Abstract][Full Text] [Related]
14. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
Shan HJ; Gu WX; Duan G; Chen HL
Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
[TBL] [Abstract][Full Text] [Related]
15. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner.
Yin Z; Guo X; Liang X; Wang Z
Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333
[TBL] [Abstract][Full Text] [Related]
16. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
17. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
18. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
19. FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.
Liu N; Liu C; Wang Z; Wang L; Wang J; Kong J
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):307-315. PubMed ID: 36628934
[TBL] [Abstract][Full Text] [Related]
20. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.
Kang H; Zhang Z; Yu L; Li Y; Liang M; Zhou L
J Cell Biochem; 2018 Jul; 119(7):5676-5685. PubMed ID: 29384213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]